Insider trades

Biotechnology Value Trading Fund OS, Officer of Kymera Therapeutics KYMR, has filed 35 purchases and 25 sales on the open market. Over the past 12 months that comes to a net sale of $236.6M. The latest trade was on 06/26.

Biotechnology Value Trading Fund OS

SEE REMARKS and Footnotes
First filing
23/01/19
Trades
183 trades
Buys / sales
35 / 25
12-month net buying
−$236.6M
Last trade
06/26

Trading activity

Transactions

Trade type
KYMR
Open-market sale06/2606/261,630,658 sh4 trades$106.50avg.$173,665,077No record
MLTX
Open-market sale03/3104/023,750,000 sh3 trades$16.79avg.$62,962,500−78.3%
Open-market sale25/08/0525/08/07156 sh3 trades$1.88avg.$293.28−0.0%
KYMR
Open-market buy25/06/3025/07/01317,167 sh3 trades$44.00avg.$13,955,348+875.1%
Open-market sale25/05/1625/05/20392,723 sh2 trades$27.10avg.$10,642,793.3−23.7%
Open-market sale25/01/2425/01/28650,717 sh4 trades$26.10avg.$16,983,713.7No record
Open-market sale24/10/2924/10/311,000,000 sh3 trades$14.30avg.$14,300,000−85.0%
MLTX
Open-market sale24/10/0424/10/082,000,000 sh3 trades$50.00avg.$100,000,000−60.8%
ELDN
Open-market buy24/05/0924/05/131,927,937 sh3 tradesNo stated valueNo stated valueNo record
Open-market sale23/12/1823/12/2017,161,278 sh3 trades$12.45avg.$213,657,911.1−100.0%
Open-market buy23/11/15–23/11/1623/11/171,227,301 sh6 trades$5.09avg.$6,248,888.1No record
KYMR
Open-market buy23/11/02–23/11/0323/11/06414,105 sh6 trades$12.80avg.$5,300,590.77No record
Open-market buy23/11/0223/11/03783,709 sh3 trades$3.60avg.$2,821,352.4No record
OLMA
Open-market buy23/09/1223/09/141,505,932 sh3 trades$9.84avg.$14,818,370.88No record
ELDN
Open-market buy23/05/0523/05/091,978,932 sh3 tradesNo stated valueNo stated valueNo record
KYMR
Open-market buy23/01/11–23/01/1223/01/1341,007 sh4 trades$30.51avg.$1,251,210.18+2.2%
Open-market buy23/01/05–23/01/0623/01/0922,249 sh4 trades$18.91avg.$420,823.02+1.4%